Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: yosi s who wrote (742)	5/3/1999 5:38:00 PM
From: arnie h	Read Replies (1) \| Respond to of 1386

Yosi: Your sales guess is just about where I am; up some 15% from the prior Q. Hopefully, it will turn out somewhat higher although it is hard to believe the stock price would be hovering around a 4 year low if sales were progressing. Looks like we are tied to the speculations involved with HU 211 and Temoxifen analog. I must say, I had hoped sales of Alrex and Lotemax would be significant enough to hold the price at a level that didn't depend fully on the outcome of the research programs. But, perhaps I'm just being pessimistic at this time. The Q report should be out soon and we'll have a better feel then. Arnie H